Medium materiality6/10
Sabra Health Care price target raised to $23 from $21 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises SBRA target to $23 from $21; current price $20.61; priceChangeSinceSignal -1.07.
- Barclays raises SBRA target to $23; price $20.61.
Key facts
- 01
Target: $23
- 02
Posted price: $20.61
- 03
Analyst firm: Barclays
- 04
Analyst: Richard Hightower
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.